Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.50 EUR
357.60 M EUR
3.67 B EUR
40.53 M
About BIOMERIEUX
Sector
Industry
CEO
Pierre Boulud
Website
Headquarters
Marcy l'Etoile
Founded
1967
ISIN
FR0013280286
FIGI
BBG00X8QLQY3
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIM is 99.25 EUR — it hasn't changed in the past 24 hours. Watch BIOMERIEUX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange BIOMERIEUX stocks are traded under the ticker BIM.
BIM stock has risen by 0.71% compared to the previous week, the month change is a −6.63% fall, over the last year BIOMERIEUX has showed a 1.07% increase.
We've gathered analysts' opinions on BIOMERIEUX future price: according to them, BIM price has a max estimate of 130.00 EUR and a min estimate of 91.00 EUR. Watch BIM chart and read a more detailed BIOMERIEUX stock forecast: see what analysts think of BIOMERIEUX and suggest that you do with its stocks.
BIM stock is 0.61% volatile and has beta coefficient of 0.60. Track BIOMERIEUX stock price on the chart and check out the list of the most volatile stocks — is BIOMERIEUX there?
Today BIOMERIEUX has the market capitalization of 11.64 B, it has decreased by −1.88% over the last week.
Yes, you can track BIOMERIEUX financials in yearly and quarterly reports right on TradingView.
BIOMERIEUX is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOMERIEUX revenue for the last half-year amounts to 1.90 B EUR, despite the estimated figure of 1.88 B EUR. In the next half-year revenue is expected to reach 1.88 B EUR.
BIM net income for the last half-year is 215.30 M EUR, while the previous report showed 196.00 M EUR of net income which accounts for 9.85% change. Track more BIOMERIEUX financial stats to get the full picture.
Yes, BIM dividends are paid annually. The last dividend per share was 0.85 EUR. As of today, Dividend Yield (TTM)% is 0.86%. Tracking BIOMERIEUX dividends might help you take more informed decisions.
BIOMERIEUX dividend yield was 0.84% in 2023, and payout ratio reached 28.08%. The year before the numbers were 0.87% and 22.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 27, 2024, the company has 14.65 K employees. See our rating of the largest employees — is BIOMERIEUX on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMERIEUX EBITDA is 825.80 M EUR, and current EBITDA margin is 21.64%. See more stats in BIOMERIEUX financial statements.
Like other stocks, BIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMERIEUX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOMERIEUX technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOMERIEUX stock shows the neutral signal. See more of BIOMERIEUX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.